175 related articles for article (PubMed ID: 27458582)
1. Fusion to Hydrophobin HFBI Improves the Catalytic Performance of a Cytochrome P450 System.
Schulz S; Schumacher D; Raszkowski D; Girhard M; Urlacher VB
Front Bioeng Biotechnol; 2016; 4():57. PubMed ID: 27458582
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous detection of NADPH consumption and H
Morlock LK; Böttcher D; Bornscheuer UT
Appl Microbiol Biotechnol; 2018 Jan; 102(2):985-994. PubMed ID: 29150709
[TBL] [Abstract][Full Text] [Related]
3. Surface display of heme- and diflavin-containing cytochrome P450 BM3 in Escherichia coli: a whole cell biocatalyst for oxidation.
Yim SK; Kim DH; Jung HC; Pan JG; Kang HS; Ahn T; Yun CH
J Microbiol Biotechnol; 2010 Apr; 20(4):712-7. PubMed ID: 20467243
[TBL] [Abstract][Full Text] [Related]
4. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
5. Molecular Lego: design of molecular assemblies of P450 enzymes for nanobiotechnology.
Gilardi G; Meharenna YT; Tsotsou GE; Sadeghi SJ; Fairhead M; Giannini S
Biosens Bioelectron; 2002 Jan; 17(1-2):133-45. PubMed ID: 11742744
[TBL] [Abstract][Full Text] [Related]
6. The Flavin-Containing Reductase Domain of Cytochrome P450 BM3 Acts as a Surrogate for Mammalian NADPH-P450 Reductase.
Park SH; Kang JY; Kim DH; Ahn T; Yun CH
Biomol Ther (Seoul); 2012 Nov; 20(6):562-8. PubMed ID: 24009851
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of rat P450 2C11 fused to rat or bacterial NADPH-P450 reductase domains.
Helvig C; Capdevila JH
Biochemistry; 2000 May; 39(17):5196-205. PubMed ID: 10819987
[TBL] [Abstract][Full Text] [Related]
8. Biological diversity of cytochrome P450 redox partner systems.
McLean KJ; Luciakova D; Belcher J; Tee KL; Munro AW
Adv Exp Med Biol; 2015; 851():299-317. PubMed ID: 26002740
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic insights into a cobalt (III) sepulchrate based alternative cofactor system of P450 BM3 monooxygenase.
Panneerselvam S; Shehzad A; Mueller-Dieckmann J; Wilmanns M; Bocola M; Davari MD; Schwaneberg U
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):134-140. PubMed ID: 28739446
[TBL] [Abstract][Full Text] [Related]
10. Molecular Lego of Human Cytochrome P450: The Key Role of Heme Domain Flexibility for the Activity of the Chimeric Proteins.
Catucci G; Ciaramella A; Di Nardo G; Zhang C; Castrignanò S; Gilardi G
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408976
[TBL] [Abstract][Full Text] [Related]
11. P450BM-3; a tale of two domains--or is it three?
Peterson JA; Sevrioukova I; Truan G; Graham-Lorence SE
Steroids; 1997 Jan; 62(1):117-23. PubMed ID: 9029725
[TBL] [Abstract][Full Text] [Related]
12. Human Cytochrome P450 3A4 as a Biocatalyst: Effects of the Engineered Linker in Modulation of Coupling Efficiency in 3A4-BMR Chimeras.
Degregorio D; D'Avino S; Castrignanò S; Di Nardo G; Sadeghi SJ; Catucci G; Gilardi G
Front Pharmacol; 2017; 8():121. PubMed ID: 28377716
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the interaction between human P450 3A4 and B. megaterium reductase via engineered loops.
Castrignanò S; D'Avino S; Di Nardo G; Catucci G; Sadeghi SJ; Gilardi G
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):116-125. PubMed ID: 28734977
[TBL] [Abstract][Full Text] [Related]
14. Engineering human cytochrome P450 enzymes into catalytically self-sufficient chimeras using molecular Lego.
Dodhia VR; Fantuzzi A; Gilardi G
J Biol Inorg Chem; 2006 Oct; 11(7):903-16. PubMed ID: 16862439
[TBL] [Abstract][Full Text] [Related]
15. Genetic and biochemical characterization of the Trichoderma reesei hydrophobin HFBI.
Nakari-Setälä T; Aro N; Kalkkinen N; Alatalo E; Penttilä M
Eur J Biochem; 1996 Jan; 235(1-2):248-55. PubMed ID: 8631337
[TBL] [Abstract][Full Text] [Related]
16. Production of ω-hydroxy palmitic acid using CYP153A35 and comparison of cytochrome P450 electron transfer system in vivo.
Jung E; Park BG; Ahsan MM; Kim J; Yun H; Choi KY; Kim BG
Appl Microbiol Biotechnol; 2016 Dec; 100(24):10375-10384. PubMed ID: 27344594
[TBL] [Abstract][Full Text] [Related]
17. Overproduction, purification, and characterization of the Trichoderma reesei hydrophobin HFBI.
Askolin S; Nakari-Setälä T; Tenkanen M
Appl Microbiol Biotechnol; 2001 Oct; 57(1-2):124-30. PubMed ID: 11693908
[TBL] [Abstract][Full Text] [Related]
18. Engineering Macaca fascicularis cytochrome P450 2C20 to reduce animal testing for new drugs.
Rua F; Sadeghi SJ; Castrignanò S; Di Nardo G; Gilardi G
J Inorg Biochem; 2012 Dec; 117():277-84. PubMed ID: 22819650
[TBL] [Abstract][Full Text] [Related]
19. Behavior of Trichoderma reesei hydrophobins in solution: interactions, dynamics, and multimer formation.
Szilvay GR; Nakari-Setälä T; Linder MB
Biochemistry; 2006 Jul; 45(28):8590-8. PubMed ID: 16834333
[TBL] [Abstract][Full Text] [Related]
20. A Novel NADPH-dependent flavoprotein reductase from Bacillus megaterium acts as an efficient cytochrome P450 reductase.
Milhim M; Gerber A; Neunzig J; Hannemann F; Bernhardt R
J Biotechnol; 2016 Aug; 231():83-94. PubMed ID: 27238232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
